0000928054FALSE00009280542023-11-072023-11-07

UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

FORM 8-K

CURRENT REPORT
Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934

November 7, 2023
Date of Report (Date of earliest event reported)

Flotek Industries, Inc.
(Exact name of registrant as specified in its charter)

Delaware001-1327090-0023731
(State or Other Jurisdiction of Incorporation)(Commission File Number)(IRS Employer Identification No.)
5775 N. Sam Houston Parkway W., Suite 400 Houston, TX, 77086
(Address of principal executive office and zip code)

(713) 849-9911
(Registrant’s telephone number, including area code)

(Not applicable)
(Former name or former address, if changed since last report)

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:

    Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)

    Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)

    Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))

    Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

Securities registered pursuant to Section 12(b) of the Act:

Title of each classTrading Symbol(s)Name of Exchange on which registered
Common Stock, $0.0001 par valueFTKNYSE

Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter).

Emerging growth company

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐






Item 2.02
Results of Operations and Financial Condition
On November 7, 2023, Flotek Industries, Inc. (the “Company”) issued a press release providing its financial results for the quarter ended September 30, 2023 and announcing that it will hold a conference call to discuss its operating results. The press release is furnished herewith as Exhibit 99.1 to this Current Report on Form 8-K and is incorporated herein by reference.

The information furnished pursuant to Item 2.02 of this Current Report on Form 8-K and in Exhibit 99.1 shall not be deemed to be “filed” for the purposes of Section 18 of the Securities Exchange Act of 1934, as amended (the “Exchange Act”), is not subject to the liabilities of that section and is not deemed incorporated by reference into any filing of the Company under the Securities Act of 1933, as amended, or the Exchange Act, except as otherwise expressly stated in such filing.


Item 7.01
Regulation FD Disclosure


On November 7, 2023, the Company provided on its website a presentation containing information relating to its current operations and financial results. A copy of the presentation is attached hereto as Exhibit 99.2 and is incorporated herein by reference.

The information furnished pursuant to Item 7.01 of this Current Report on 8-K and in Exhibit 99.2 shall not be deemed to be “filed” for the purposes of Section 18 of the Exchange Act, is not subject to the liabilities of that section and is not deemed incorporated by reference into any filing of the Company under the Securities Act of 1933, as amended, or the Exchange Act, except as otherwise expressly stated in such filing.


Item 9.01
Financial Statements and Exhibits.

d) Exhibits.




SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

FLOTEK INDUSTRIES, INC.
Date: November 7, 2023/s/ Bond Clement
Name:Bond Clement
Title:Chief Financial Officer



Exhibit 99.1
newlogo.jpg
Flotek Reports Third Quarter 2023 Financial Results Driven by Strong Growth in
Net Income and First Positive Adjusted EBITDA Quarter Since 2018

HOUSTON, November 7, 2023 - Flotek Industries, Inc. (“Flotek” or the “Company”) (NYSE: FTK) today announced operational and financial results for the third quarter ended September 30, 2023, highlighted by significant improvement in all profitability metrics, including net income and the first quarter of positive adjusted EBITDA(1) since the third quarter of 2018. The third quarter results build upon the Company’s financial and operational momentum with nearly all financial metrics showing strong year-over-year growth.

Financial Summary (in thousands)

Three months ended September 30, Nine months ended September 30,
2023202220232022
Total Revenues$47,268 $45,623 $145,870 $87,874 
Gross Profit (Loss)$9,047 $(1,842)$14,833 $(4,626)
Adjusted Gross Profit (Loss) (1)
$10,264 $249 $18,005 $(916)
Net Income (Loss)$1,287 $(18,794)$22,609 $(23,278)
Adjusted EBITDA (1)
$3,392 $(8,402)$(2,464)$(21,088)

(1)A non-GAAP financial measure. See the “Unaudited Reconciliation of Non-GAAP Items and Non-Cash Items Impacting Earnings” section in this release for more information, including reconciliations to the most comparable GAAP measures.

Third Quarter 2023 Highlights

Reported net income of $1.3 million, or $0.04 per diluted share, compared to a net loss of $18.8 million or ($1.50) per diluted share for the third quarter of 2022.
Achieved positive adjusted EBITDA(1) of $3.4 million, an increase of $11.8 million compared to the third quarter of 2022. This is the ninth consecutive quarter of improvement and marks the first quarter of positive adjusted EBITDA since the third quarter of 2018.
Reported gross profit of $9.0 million and adjusted gross profit(1) of $10.3 million marking the third consecutive quarter of positive results in both metrics. Gross profit margin and adjusted gross profit margin(1) for the third quarter of 2023 improved to 19% and 22%, respectively.
Strengthened liquidity through an Asset Based Loan, which was increased from $10.0 million to $13.8 million in October.
Solidified the senior leadership team with the addition of four key members that bring substantial experience and strategic focus on sales, supply chain, people and data analytics.
Completed move to new company headquarters, which is expected to result in annual savings of approximately $1 million.

(1)A non-GAAP financial measure. See the “Unaudited Reconciliation of Non-GAAP Items and Non-Cash Items Impacting Earnings” section in this release for more information, including reconciliations to the most comparable GAAP measures.

1




Full Year 2023 Outlook

Flotek is updating its full year 2023 guidance as follows:

Adjusted gross profit margin(2) is expected to increase to 12% to 14%, up from the previous range of 8% to 10%.
Total revenues are expected to be $185 million to $200 million, compared to a previous estimate of $210 million to $230 million. The decrease in revenue guidance is due to an overall market slowdown in upstream onshore activity as reflected by the reduction in drilling rigs and completion fleets operating. Specifically, the U.S. land rig count is down 19% and frac fleet activity is down 12% from the third quarter of 2022. Despite this market slowdown, the Company’s non-ProFrac chemistry revenues have grown each quarter in 2023 and increased another 5% during the third quarter of 2023.

(2)A non-GAAP financial measure. See the “Unaudited Reconciliation of Non-GAAP Items and Non-Cash Items Impacting Earnings” section in this release for more information, including reconciliations to the most comparable GAAP measures. We are unable to reconcile this forward-looking non-GAAP financial measure to the most directly comparable GAAP financial measure without unreasonable efforts, as we are unable to predict with a reasonable degree of certainty the impact of certain items that would be expected to impact the GAAP financial measure, including, among other items, the future amortization of our contract assets, certain stock-based compensation costs and the impact of the revaluation of certain liabilities, which is based upon our future stock price. These items do not impact the non-GAAP financial measure.

Management Commentary

Chief Executive Officer Dr. Ryan Ezell commented, “I’m pleased with our third quarter results as we delivered significant improvement in nearly all financial metrics highlighted by quarterly adjusted EBITDA turning positive for the first time in five years. These results build upon the strong financial and operational momentum we have established this year through the execution of our strategy to be the collaborative partner of choice for innovative chemical and data solutions. We also achieved a significant milestone with the closing of an Asset Based Loan that augments our liquidity and supports our future business and growth objectives. Most importantly, we executed these milestones with no recordable safety incidents in the field of operations.”

“We continue to expand our market share and margins despite industry headwinds as the importance of maximized production and rate-of-return for each well completion moves to the forefront of focus for operators. This plays to the strength of Flotek's differentiated technologies that target improved recovery from each reservoir.”

Third Quarter 2023 Financial Results

Revenue: Flotek reported total revenues of $47.3 million for the third quarter of 2023, which was an increase of 4% compared to total revenues of $45.6 million for the third quarter of 2022. The Company’s non-ProFrac chemistry revenues have grown each quarter in 2023 and increased 23% as compared to the year ago quarter. Revenues not attributable to ProFrac comprised 38% of total company revenues during the third quarter of 2023.

The Company's supply agreement with ProFrac contains minimum requirements for annual chemistry purchases. If the minimum contractual requirements are not met, the Company receives additional payments from ProFrac at the conclusion of the measurement period, which is currently June 1, 2023 through December 31, 2023. Based on recent activity, Flotek does not expect that the chemistry purchase requirements will be met during the measurement period, and as a result, third quarter
2



and nine-month 2023 revenues include estimated expected additional payments from ProFrac under the contract.

Gross Profit (Loss): The Company generated gross profit of $9.0 million during the third quarter of 2023 as compared to a gross loss of $1.8 million for the third quarter of 2022. The improvement in third quarter of 2023 gross profit was the result of the estimated additional payments expected from ProFrac related to the minimum chemistry purchase requirements discussed above as well as the increase in transactional chemistry revenue during the quarter and continued initiatives to drive further cost improvements with respect to freight logistics and materials.

Adjusted Gross Profit (Non-GAAP)(1): Flotek generated adjusted gross profit of $10.3 million during the third quarter of 2023 compared to adjusted gross profit of $0.2 million for the third quarter of 2022. Adjusted gross profit for the nine months ended September 30, 2023, increased to $18.0 million as compared to a loss of $0.9 million for the nine-month period of 2022. Adjusted gross profit primarily excludes non-cash items, including amortization of contract assets, which reduces both revenue and gross profit.

Selling, General and Administrative (“SG&A”) Expense: SG&A expense totaled $6.5 million for the third quarter of 2023 compared to $9.3 million for the third quarter of 2022. The 30% reduction in SG&A compared to the third quarter of 2022 was primarily the result of lower employee compensation expense as well as reduced legal and professional fees.

Net Income (Loss) and EPS: Flotek reported net income of $1.3 million, or $0.04 per diluted share, for the third quarter of 2023. This compares to a net loss of $18.8 million, or ($1.50) per diluted share, for the third quarter of 2022. Net income for the nine-month period ended September 30, 2023 was $22.6 million as compared to a net loss of $23.3 million for the comparable period of 2022. Net income/(loss) for the third quarter of 2022 and nine-month periods of 2023 and 2022 included non-cash gains/(losses) on the fair value measurement of convertible notes payable totaling ($4.3) million, $30.0 million, and $9.0 million, respectively.

Adjusted EBITDA (Non-GAAP)(1): Adjusted EBITDA was $3.4 million in the third quarter of 2023 as compared to negative $8.4 million in the third quarter of 2022.

(1)See the “Unaudited Reconciliation of Non-GAAP Items and Non-Cash Items Impacting Earnings” section in this release for more information, including reconciliations to the most comparable GAAP measures.

Balance Sheet and Liquidity

On August 14, 2023, the Company announced that it entered into an Asset Based Loan, providing initial credit availability of up to $10.0 million. During October, the credit availability was increased to $13.8 million based on the final appraised value of certain real estate assets pledged as collateral.

As of November 6, 2023, the Company’s liquidity totaled $9.0 million, consisting of $2.6 million of cash and cash equivalents and $6.4 million of availability under the Asset Based Loan.

Conference Call Details

Flotek will host a conference call on November 8, 2023, at 9:00 a.m. CDT (10:00 a.m. EDT) to discuss its third quarter 2023 results. Participants may access the call through Flotek’s website at www.flotekind.com under “Webcasts’’ or by telephone toll free at 1-844-835-9986
3



(international toll: 1-412-317-5270) approximately five minutes prior to the start of the call. Following the conclusion of the conference call, a recording of the call will be available on the Company’s website.

About Flotek Industries, Inc.

Flotek Industries, Inc. is an advanced technology-driven, green chemical and data analytics company providing unique and innovative completion solutions that have a proven, positive impact on sustainability and reducing the overall environmental impact of energy on air, land, water and people. Flotek has an intellectual property portfolio of over 170 patents and a global presence in more than 15 countries throughout North America, Latin America, the Middle East and North Africa. Flotek has established collaborative partnerships focused on sustainable and optimized chemistry and data solutions which improve well performance and allow its customers to generate higher returns on invested capital.

Flotek is based in Houston, Texas and its common shares are traded on the New York Stock Exchange under the ticker symbol “FTK”. For additional information, please visit www.flotekind.com.

Forward-Looking Statements

Certain statements set forth in this press release constitute forward-looking statements (within the meaning of Section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934) regarding Flotek Industries, Inc.’s business, financial condition, results of operations and prospects. Words such as will, continue, expects, anticipates, intends, plans, believes, seeks, estimates and similar expressions or variations of such words are intended to identify forward-looking statements, but are not the exclusive means of identifying forward-looking statements in this press release. Although forward-looking statements in this press release reflect the good faith judgment of management, such statements can only be based on facts and factors currently known to management. Consequently, forward-looking statements are inherently subject to risks and uncertainties, and actual results and outcomes may differ materially from the results and outcomes discussed in the forward-looking statements. Further information about the risks and uncertainties that may impact the company are set forth in the Company’s most recent filing with the Securities and Exchange Commission on Form 10-K (including, without limitation, in the “Risk Factors” section thereof), and in the Company’s other SEC filings and publicly available documents. Readers are urged not to place undue reliance on these forward-looking statements, which speak only as of the date of this press release. The Company undertakes no obligation to revise or update any forward-looking statements in order to reflect any event or circumstance that may arise after the date of this press release.


Investor contact:
Bond Clement
Chief Financial Officer
E: ir@flotekind.com
P: (713) 726-5322
4




FLOTEK INDUSTRIES, INC.
UNAUDITED CONDENSED CONSOLIDATED BALANCE SHEETS
(in thousands, except share data)

September 30, 2023December 31, 2022
ASSETS
Current assets:
Cash and cash equivalents$4,453 $12,290 
Restricted cash102 100 
Accounts receivable, net of allowance for credit losses of $704 and $623 at September 30, 2023 and December 31, 2022, respectively15,568 19,136 
Accounts receivable, related party, net of allowance for credit losses of $0 at September 30, 2023 and December 31, 2022, respectively24,765 22,683 
Inventories, net15,885 15,720 
Other current assets4,617 4,045 
Current contract asset7,816 7,113 
Total current assets73,206 81,087 
Long-term contract assets68,207 72,576 
Property and equipment, net4,844 4,826 
Operating lease right-of-use assets5,131 5,900 
Deferred tax assets, net355 404 
Other long-term assets773 17 
TOTAL ASSETS$152,516 $164,810 
LIABILITIES AND STOCKHOLDERS’ EQUITY
Current liabilities:
Accounts payable$33,436 $33,375 
Accrued liabilities5,430 8,984 
Income taxes payable43 97 
Interest payable— 130 
Current portion of operating lease liabilities2,747 3,328 
Current portion of finance lease liabilities31 36 
Current portion of long-term debt179 2,052 
Asset based loan3,370 — 
Convertible notes payable— 19,799 
Contract Consideration Convertible Notes Payable— 83,570 
Total current liabilities45,236 151,371 
Deferred revenue, long-term35 44 
Long-term operating lease liabilities7,537 8,044 
Long-term finance lease liabilities— 19 
Long-term debt104 2,736 
TOTAL LIABILITIES52,912 162,214 
Stockholders’ equity:
Preferred stock, $0.0001 par value, 100,000 shares authorized; no shares issued and outstanding— — 
Common stock, $0.0001 par value, 240,000,000 shares authorized; 30,739,820 shares issued and 29,629,902 shares outstanding at September 30, 2023; 13,985,986 shares issued and 12,964,732 shares outstanding at December 31, 2022
Additional paid-in capital462,799 388,184 
Accumulated other comprehensive income 194 181 
Accumulated deficit(328,910)(351,519)
Treasury stock, at cost; 1,109,918 and 1,021,255 shares at September 30, 2023 and December 31, 2022, respectively(34,482)(34,251)
Total stockholders’ equity99,604 2,596 
TOTAL LIABILITIES AND STOCKHOLDERS’ EQUITY$152,516 $164,810 
5



FLOTEK INDUSTRIES, INC.
Unaudited Condensed Consolidated Statements of Operations
(in thousands, except per share data)
 Three Months EndedNine Months Ended
 9/30/20239/30/20229/30/20239/30/2022
Revenue:
Revenue from external customers$17,806 $15,206 $47,278 $38,412 
Revenue from related party29,462 30,417 98,592 49,462 
Total revenues47,268 45,623 145,870 87,874 
Cost of goods sold38,221 47,465 131,037 92,500 
Gross profit (loss)9,047 (1,842)14,833 (4,626)
Operating costs and expenses:
Selling, general, and administrative6,526 9,254 21,303 20,958 
Depreciation181 177 530 554 
Research and development757 985 2,231 3,515 
Severance costs(219)(28)387 
Gain on sale of property and equipment(38)(10)(38)(1,916)
Gain on lease termination— — — (584)
(Gain) loss in fair value of Contract Consideration Convertible Notes Payable— 4,250 (29,969)(9,016)
Total operating costs and expenses7,428 14,437 (5,971)13,898 
Income (loss) from operations1,619 (16,279)20,804 (18,524)
Other income (expense):
Paycheck protection plan loan forgiveness— — 4,522 — 
Interest expense(160)(2,321)(2,537)(4,586)
Other expense, net(91)(187)(82)(67)
Total other income (expense), net(251)(2,508)1,903 (4,653)
Income (loss) before income taxes1,368 (18,787)22,707 (23,177)
Income tax expense(81)(7)(98)(101)
Net income (loss)$1,287 $(18,794)$22,609 $(23,278)
Income (loss) per common share:
Basic$0.04 $(1.50)$0.97 $(1.89)
Diluted$0.04 $(1.50)$(0.18)$(1.89)
Weighted average common shares:
Weighted average common shares used in computing basic income (loss) per common share29,358 12,552 23,291 12,349 
Weighted average common shares used in computing diluted income (loss) per common share30,688 12,552 28,034 12,349 
6



FLOTEK INDUSTRIES, INC.
UNAUDITED CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS
(in thousands)

 Nine months ended September 30,
 20232022
Cash flows from operating activities:
Net income (loss)$22,609 $(23,278)
Adjustments to reconcile net income (loss) to net cash used in operating activities:
Change in fair value of contingent consideration(384)(106)
Change in fair value of Contract Consideration Convertible Notes Payable(29,969)(9,016)
Amortization of convertible note issuance costs83 663 
Payment-in-kind interest expense2,284 3,861 
Amortization of contract assets3,665 1,986 
Depreciation and amortization530 554 
Amortization of asset based loan origination costs36 — 
Provision for credit losses, net of recoveries97 147 
Provision for excess and obsolete inventory626 1,702 
Gain on sale of property and equipment(38)(1,916)
Gain on lease termination— (584)
Non-cash lease expense2,316 168 
Stock compensation expense(565)2,262 
Deferred income tax (benefit) expense50 
Paycheck protection plan loan forgiveness(4,522)— 
Changes in current assets and liabilities:
Accounts receivable3,472 (5,748)
Accounts receivable, related party(2,082)(24,616)
Inventories(776)(11,373)
Income taxes receivable— 
Other assets(863)(537)
Contract assets, net— (3,600)
Accounts payable60 22,036 
Accrued liabilities(3,179)493 
Operating lease liabilities(2,636)(404)
Income taxes payable(54)100 
Interest payable(8)36 
Net cash used in operating activities(9,248)(47,166)










7



FLOTEK INDUSTRIES, INC.
UNAUDITED CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS
(in thousands)
(continued)

Nine months ended September 30,
20232022
Cash flows from investing activities:
Capital expenditures(593)(175)
Proceeds from sale of assets68 4,215 
Net cash (used in) provided by investing activities(525)4,040 
Cash flows from financing activities:
Payment for forfeited stock options(617)— 
Payments on long term debt(104)— 
Proceeds from asset based loan27,750 — 
Payments on asset based loan(24,380)— 
Payment for origination costs of asset based loan(502)— 
Proceeds from issuance of convertible notes— 21,150 
Payment of issuance costs of convertible notes— (1,084)
Proceeds from issuance of warrants— 19,500 
Payment of issuance costs of stock warrants— (1,170)
Payments to tax authorities for shares withheld from employees(246)(191)
Proceeds from issuance of stock 48 24 
Payments for finance leases(24)(30)
Net cash provided by financing activities1,925 38,199 
Effect of changes in exchange rates on cash and cash equivalents13 211 
Net change in cash and cash equivalents and restricted cash(7,835)(4,716)
Cash and cash equivalents at the beginning of period12,290 11,534 
Restricted cash at the beginning of period100 1,790 
Cash and cash equivalents and restricted cash at beginning of period12,390 13,324 
Cash and cash equivalents at end of period4,453 8,508 
Restricted cash at the end of period102 100 
Cash and cash equivalents and restricted cash at end of period$4,555 $8,608 
8



FLOTEK INDUSTRIES, INC.
Unaudited Reconciliation of Non-GAAP Items and Non-Cash Items Impacting Earnings
(in thousands)

 Three Months EndedNine Months Ended
 9/30/20239/30/20229/30/20239/30/2022
Gross profit (loss)$9,047 $(1,842)$14,833 $(4,626)
Stock compensation expense256 (135)783 
Severance and retirement— (478)26 11 
Contingent liability revaluation(61)28 (384)(106)
Sanitizer inventory write down— 1,036 — 1,036 
Amortization of contract assets1,276 1,249 3,665 1,986 
Adjusted Gross profit (loss) (1)
$10,264 $249 $18,005 $(916)
Net income (loss)$1,287 $(18,794)$22,609 $(23,278)
Interest expense160 2,321 2,537 4,586 
Income tax expense81 98 101 
Depreciation and amortization181 177 530 554 
EBITDA (Non-GAAP)$1,709 $(16,289)$25,774 $(18,037)
Stock compensation expense268 671 (574)2,263 
Severance and retirement(219)(28)387 
Contingent liability revaluation(61)28 (384)(106)
Sanitizer inventory write down— 1,036 — 1,036 
Gain on disposal of assets(38)(10)(38)(1,916)
Gain on lease termination— — — (584)
PPP loan forgiveness— — (4,522)— 
Contract Consideration Convertible Notes Payable revaluation adjustment— 4,250 (29,969)(9,016)
Amortization of contract assets1,276 1,249 3,665 1,986 
Non-Recurring professional fees236 882 3,612 2,899 
Adjusted EBITDA (Non-GAAP) (1)
$3,392 $(8,402)$(2,464)$(21,088)

(1) Management believes that adjusted gross profit and adjusted EBITDA for the three and nine months ended September 30, 2023 and 2022, are useful to investors to assess and understand operating performance, especially when comparing those results with previous and subsequent periods. Management views the income and expenses noted above to be outside of the Company’s normal operating results. Management analyses operating results without the impact of the above items as an indicator of performance, to identify underlying trends in the business and cash flow from continuing operations, and to establish financial and operational goals, excluding certain non-cash or non-recurring items.
9
Corporate Update November 2023


 
Forward-Looking Statements Certain statements set forth in this presentation constitute forward-looking statements (within the meaning of Section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934) regarding Flotek Industries, Inc.’s business, financial condition, results of operations and prospects. Words such as will, continue, expects, anticipates, intends, plans, believes, seeks, estimates and similar expressions or variations of such words are intended to identify forward-looking statements, but are not the exclusive means of identifying forward-looking statements in this presentation. Although forward- looking statements in this presentation reflect the good faith judgment of management, such statements can only be based on facts and factors currently known to management. Consequently, forward-looking statements are inherently subject to risks and uncertainties, and actual results and outcomes may differ materially from the results and outcomes discussed in the forward-looking statements. Further information about the risks and uncertainties that may impact the Company are set forth in the Company’s most recent filing with the Securities and Exchange Commission on Form 10-K (including, without limitation, in the "Risk Factors" section thereof), and in the Company’s other SEC filings and publicly available documents. Readers are urged not to place undue reliance on these forward-looking statements, which speak only as of the date of this presentation. The Company undertakes no obligation to revise or update any forward-looking statements in order to reflect any event or circumstance that may arise after the date of this presentation. // 2


 
Flotek is a Compelling Investment Choice // 3 • Strong leadership team with deep industry expertise to execute strategy • Fit-for-purpose chemistry and data analytics solutions continue to present differentiated value proposition • Contractual commitments under the ProFrac agreement mitigate impact of the industry slowdown • Cost control initiatives drive increased profitability and transition to positive adj. EBITDA* • Expanded global footprint with a new entity in Abu Dhabi, reducing costs and improving sales potential • Strengthened liquidity through ABL facility * Adjusted EBITDA is a non-GAAP measure. See the Appendix in this presentation for a reconciliation to the nearest GAAP measure. SIGNIFICANT IMPROVEMENT IN BUSINESS FUNDAMENTALS NOT REFLECTED IN SHARE PRICE


 
Corporate Snapshot Abu Dhabi, UAE Raceland, LAMarlow, OK Houston, TX (HQ) Headquarters Field Office // 4 FTK Global Presence Founded: 1985 Employees: 143 Corporate Headquarters: Houston Countries with Clients: >15 Patents: >170 Debt (09.30.23) ($mm): $3.5 3Q 2023 Adj. Gross Profit Margin: 22% 2023 GUIDANCE Revenue ($mm): $185 - $200 Adj. Gross Profit Margin: 12 - 14%


 
Flotek: A Purpose-Driven Company // 5 Our completion solutions have a proven, positive impact on sustainability and reducing the overall environmental impact of energy on air, land, water and people Who We Are An advanced technology-driven, green chemical and data analytics company providing unique and innovative completion solutions Our Vision We strive to be the collaborative partner of choice for solutions that reduce the environmental impact of energy on air, water, land and people Compelling Value Proposition We collaborate and deliver sustainable, optimized chemistry and data solutions that maximize our customer’s value


 
Our Strategic Priorities Industry-Leading Innovation Track record of delivering fit-for-purpose optimized chemistry and data solutions Capital-Light Growth Modest capital required to support robust growth objectives Environmental Leadership Focus on reducing impact on people, land, air, and water // 6 Sustainable Revenue 10-year contract with ProFrac generates a guaranteed minimum of $2B+ Enhanced Profitability 3Q 2023 was first quarter of positive adjusted EBITDA** since 2018 Strong Balance Sheet Minimal debt and strengthened liquidity with new ABL* facility * Asset Based Loan ** Adjusted EBITDA is a non-GAAP measure. See the Appendix in this presentation for a reconciliation to the nearest GAAP measure.


 
Market Update: Sequential Drop in Activity // 7 Energy Sector Factors (Frac Services) • Active frac fleets down Q/Q • Tier II fleets being idled and many retired • Tier IV and E-Fleets remain in high utilization 270 Fleets As of 11/3 618 Rigs As of 11/3 Energy Sector Factors (Drilling Services) • Changes since 3Q 2022 – Land rig count is down 152 – Crude oil rig count is at 502, down 17% – Natural gas rig count is at 116, down 27% Source: AOGR Source: AOGR


 
Third Quarter 2023 Highlights // 8 • Reported positive adj. EBITDA* for the first time in five years and the ninth consecutive quarter of improvement • Transactional (“Non-ProFrac”) chemistry revenues have grown each quarter in 2023, mitigating impact of activity slowdown • Reported 128% growth in proprietary CnF chemistry sales • Adjusted gross profit* was positive for the third consecutive quarter with an associated margin of 22% • Strengthened liquidity through a $10 million ABL that was upsized to $13.8 million in October • Data Analytics subscription revenue up 81% from first 9 months of 2022 * Adjusted Gross Profit (Loss) and Adjusted EBITDA are non-GAAP measures. See the Appendix in this presentation for a reconciliation to the nearest GAAP measure. Full year 2023 revenue of $185MM – $200MM and adjusted gross profit* margin of 12% – 14% OPERATIONAL PERFORMANCE DRIVES STRONG GROWTH IN YEAR-OVER-YEAR PROFITABILITY METRICS


 
$0 $50,000 $100,000 $150,000 $200,000 $250,000 2020 2021 2022 2023 Strong Growth in Revenues // 9 • 3Q 2023 total revenues grew 4% year-over-year despite overall industry-wide activity slowdown • Transactional chemistry revenues have grown each quarter in 2023, mitigating impact of activity slowdown • Anticipate 41% growth in 2023 total revenues* • Revenue growth supported by ProFrac contract and sustained growth in non-ProFrac chemistry business Annual Consolidated Revenue (000’s) $185 $200 Guidance Range * Based on mid point of 2023 revenue guidance .


 
Delivering Rapid Improvement in Gross Profit Quarterly Consolidated Gross Profit (Loss) (000’s) // 10 • 3Q 2023 gross profit was positive for the third consecutive quarter • Anticipate ~$27MM** increase in 2023 adjusted gross profit* compared to 2022 • ProFrac contract protects against lower frac fleet activity • Delivered efficiencies across all aspects of business supply chain ($2,500) $0 $2,500 $5,000 $7,500 $10,000 Q1 2022 Q2 2022 Q3 2022 Q4 2022 Q1 2023 Q2 2023 Q3 2023 • Adjusted Gross Profit (Loss) and Adjusted EBITDA are non-GAAP measures. See the Appendix in this presentation for a reconciliation to the nearest GAAP measure. ** Based on the mid point of 2023 guidance.


 
Strong Financial Momentum Continues // 11 Quarterly Adjusted EBITDA*/Revenue * Adjusted EBITDA is a non-GAAP metric. See the Appendix in this presentation for a reconciliation to nearest GAAP measure -80% -70% -60% -50% -40% -30% -20% -10% 0% 10% 20% 2Q21 3Q21 4Q21 1Q22 2Q22 3Q22 4Q22 1Q23 2Q23 3Q23 • 3Q 2023 adj. EBITDA* increased $11.7MM over 3Q 2022 • The first quarter of positive adj. EBITDA since 3Q 2018 • Ninth consecutive quarter of improvement


 
• Global presence in over 15 countries • Establishing collaborative partnerships with E&P operators and oil field service providers • Extensive experience with proven solutions in over 20,000 completion wells worldwide • Fit-for-purpose optimized chemistry and data solutions allow customers to maximize the value of their business • High margin data analytics segment driving revenue growth and increased profitability • Increasing market share across both segments Complementary Segments Deliver Sustainable Growth Sustainable chemistry solutions to maximize customer’s value chain while minimizing their environmental impact Transforming business through real-time data, monitoring and visualization across the energy value chain utilizing proprietary JP3 unit Chemistry Technologies Data Analytics // 12 GENERATING VALUE VIA DIRECT AND IN-DIRECT CHANNELS


 
Chemistry Technologies Business Overview // 13 • Technologically advanced products and services that significantly improve well performance and maximize value of customer’s business • Extensive portfolio of customized solutions that support operations across the value chain • Industry leader in delivering innovative products that increase performance while reducing costs • Strong presence across all major U.S. shale basins • Creative solutions to reduce the environmental impact of energy on air, water, land and people


 
Chemistry Technologies Applications // 14 Positioned to capitalize on strong growth cycle of responsible energy production via collaborative partnership with customers Drilling & Cementing Fluids to protect the reservoir and environment Enhancing maximum efficiency of productivity STIMULATION Drilling & Cementing Fluids to protect the reservoir and environment Chemistries for enduring performance PRODUCTION Sustainable chemistry maximizing recovery REMEDIATION Drilling & Cementing Fluids to protect the reservoir and environment Effective solutions for gre ter recovery ENHANCED WATER FLOODING Fluids to protect the reservoir and the environment DRILLING & CEMENTING Chemistries that minimize formation damage and extend asset life OFFSHORE A STRONG POSITION OF EXPERTISE IN ENERGY CHEMISTRY


 
0 50,000 100,000 150,000 200,000 250,000 300,000 350,000 400,000 0 5 10 15 20 C u m u la tiv e P ro d u c tio n (B O E) Months Permian Basin Average Cumulative BOE Flotek PCM Non-Flotek 25 +26% Uplift Chemistry Technologies: The Flotek Advantage // 15 • Prescriptive Chemistry Management (PCM) • Proprietary energy chemistry solutions • Dedicated chemistry management team • Customized solutions to each well’s geology • World class lab testing capabilities • AI enabled and digital twinning analytics of over 20,000 wells • CnF is our proprietary reservoir technology utilized by PCM services • Leveraging over 170 active patents to design the best chemistry for each well • Strong well performance with 75,000 BOE more uplift than competition * Data derived from 2019-2023 Enverus Prism Platform (1,878 wells) ** Similar Results from all basins, example is highlighting the most productive basin in the U.S. (Permian) 75 MBOE} * DELIVERING THE BEST UPLIFT PERFORMANCE IN INDUSTRY $2.9 $6.6 $0.0 $1.0 $2.0 $3.0 $4.0 $5.0 $6.0 $7.0 Q2 Q3 CnF Revenue Performance 128% growth R e ve n u e s ($ in M M )


 
Leveraging New Markets Diversifies Customer Base // 16 PROVIDES SIGNIFICANT FUTURE GROWTH OPPORTUNITY Industrial Geothermal Agricultural Solar Hydrogen As smart systems develop, so will the demand for green chemistry solutions Positioned to capitalize on proprietary patents, technology advancements and collaborative partnerships with customers


 
Data Analytics Business Overview // 17 • Provides accurate, real-time visibility into chemical composition flowing directly through a well-head, pipeline, power generator, refinery, and more. • Robust platform based on NIR Spectroscopy; doesn’t utilize consumables and there are no moving parts • Ability to operate in highly variable field conditions • Field trial of next generation JP3 Spectrometer Prototype in progress • Remote monitoring enables operators to access data remotely through JP3’s VIPER web app • Assists customers on path to net zero emissions


 
// 18 JP3 Units Deployed Broad Deployment and Utilization of JP3 Units 81 customers across all key basins 306 field units deployed with 635 individual measurement points


 
// 19 One Technology Platform Multiple Applications Data Analytics: Extensive Industry Applications Upstream • Realtime product measurement improves accuracy of payments to royalty owners and operators • Continuous BTU monitoring to facilitate field gas utilization in powering rigs and frac fleets • Flare monitoring and methane detection Midstream • Gas processing plant control and optimization • Pipeline batch detection to optimize pipeline transmix processes • Vapor pressure controls to achieve product specifications • Emerging market in carbon capture Downstream • Realtime measurement to optimize distillation tower efficiency • Crude feedstock blending • Chemical property and quality measurement in pipelines and terminals • Refined product specification measurement to optimize mix of products


 
• JP3 field gas monitoring system allows frac fleets and drilling rigs to safely run on field gas displacing more expensive and higher carbon footprint diesel • A three-pad customer case study July - August 2023: • Achieved 70% field gas substitution rate • Eliminated 1.2MM gallons of diesel usage • Realized 100% uptime Data Analytics: Upstream Field Gas Usage // 20 70% Reduction in Diesel/CNG usage Frac Trailer Mounted System


 
• Upstream Custody Transfer challenges: • Readings only taken every 3 to 6 weeks with gas chromatography (gc) • Paid less on inconsistent readings impacted by temperature, timing, and conditions • Requires onsite personnel • JP3 technology changes the market: • Accurate readings every 5 seconds • Stakeholders paid on more consistent hydrocarbon quality readings • Autonomous measurement Data Analytics: Upstream Market Disruptor // 21 From 3 weeks to 5 Seconds! Mobile App and SCADA Reporting Real-Time Wellsite Readings Local System


 
Summary // 22 • Strong leadership team with deep industry expertise to execute strategy • Fit-for-purpose chemistry and data analytics solutions continue to present differentiated value proposition • Contractual chemistry commitments under the ProFrac agreement mitigates impact of the industry slowdown • Cost control initiatives drive increased profitability and transition to positive Adj. EBITDA* • Expanded our global footprint with a new entity in Abu Dhabi, reducing costs and improving sales potential • Strengthened liquidity through ABL facility * Adjusted EBITDA is a non-GAAP measure. See the Appendix in this presentation for a reconciliation to the nearest GAAP measure.


 
Appendix


 
Recent Financials Unaudited Condensed Consolidated Statement of Operations (in thousands, except share data) // 24


 
Unaudited Condensed Consolidated Balance Sheets (in thousands, except share data) // 25


 
Unaudited Condensed Consolidated Statements of Cash Flows (in thousands) // 26


 
Unaudited Reconciliation of Non-GAAP Items and Non-Cash Items Impacting Earnings (in thousands)(1) // 27 (1) Management believes that adjusted gross profit and adjusted EBITDA for the three and nine months ended September 30, 2023 and 2022, are useful to investors to assess and understand operating performance, especially when comparing those results with previous and subsequent periods. Management views the income and expenses noted above to be outside of the Company’s normal operating results. Management analyses operating results without the impact of the above items as an indicator of performance, to identify underlying trends in the business and cash flow from continuing operations, and to establish financial and operational goals, excluding certain non-cash or non-recurring items.


 
Investor Contact Bond Clement Chief Financial Officer ir@flotekind.com (713) 726-5322


 
v3.23.3
Cover
Nov. 07, 2023
Cover [Abstract]  
Document Type 8-K
Document Period End Date Nov. 07, 2023
Entity Registrant Name Flotek Industries, Inc.
Entity Incorporation, State or Country Code DE
Entity File Number 001-13270
Entity Tax Identification Number 90-0023731
Entity Address, Address Line One 5775 N. Sam Houston Parkway W., Suite 400
Entity Address, City or Town Houston
Entity Address, State or Province TX
Entity Address, Postal Zip Code 77086
City Area Code (713)
Local Phone Number 849-9911
Soliciting Material false
Written Communications false
Pre-commencement Tender Offer false
Pre-commencement Issuer Tender Offer false
Title of 12(b) Security Common Stock, $0.0001 par value
Trading Symbol FTK
Security Exchange Name NYSE
Entity Emerging Growth Company false
Entity Central Index Key 0000928054
Amendment Flag false
Entity Addresses [Line Items]  
City Area Code (713)
Local Phone Number 849-9911

Flotek Industries (NYSE:FTK)
Historical Stock Chart
From Mar 2024 to Apr 2024 Click Here for more Flotek Industries Charts.
Flotek Industries (NYSE:FTK)
Historical Stock Chart
From Apr 2023 to Apr 2024 Click Here for more Flotek Industries Charts.